(19)

(11)

EP 3 003 273 A1

(12)

(43) Date of publication: 13.04.2016 Bulletin 2016/15 (21) Application number: 14728902.9 (22) Date of filing: 30.05.2014

(51) International Patent Classification (IPC):  A61K 9/08(2006.01) A61K 47/04(2006.01) A61K 31/65(2006.01) A61K 9/19(2006.01) A61K 47/26(2006.01) A61K 9/00(2006.01) (86) International application number: PCT/EP2014/061253 (87) International publication number: WO 2014/191552 (04.12.2014 Gazette 2014/49)

(84) Designated Contracting States: AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR Designated Extension States: BA ME (30) Priority: 31.05.2013 NO 20130759 (71) Applicant: Xellia Pharmaceuticals ApS 2300 Copenhagen S (DK)	(72) Inventors: JASPRICA, Ivona HR-10000 Zagreb (HR) GRUBESIC, Sasa HR-10000 Zagreb (HR) BEVETEK MOCNIK, Anita HR-10361 Sesvetski Kraljevec (HR) (74) Representative: Onsagers AS  P.O. Box 1813 Vika 0123 Oslo 0123 Oslo (NO)